Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

NCT00900588 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)

Sponsor

Sinovac Biotech Co., Ltd

Collaborators

[object Object]